USC - Volume 11 Issue 1 Spring 2017

USC - Volume 11 Issue 1 Spring 2017
Login or register to view PDF.

The editorial board and staff are pleased to present the latest issue of US Cardiology Review. The submissions include reviews, editorials, and perspectives based on recently published clinical trials. They have been selected based on relevance to daily practice of the general cardiologist and advanced internist.

This issue is a busy one and has been the result of much effort. I thank the editorial staff, our reviewers, and the authors for their hard work in these contributions. We trust you will find the results informative for your practice.

 
 
Foreword
Donald E Cutlip , 
Citation: US Cardiology Review 2017;11(1):4
DOI: https://doi.org/10.15420/usc.2017:11:1:4
HTML | ePub | Login or register to view PDF. | Permissions
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.

Risk and Prevention

Do We Need a Different Approach to Assess Cardiovascular Risk in Women?
Ijeoma Isiadinso ,  Nanette K Wenger , 
Citation: US Cardiology Review 2017;11(1):5–9
DOI: https://doi.org/10.15420/usc.2016:8:2
HTML | ePub | Login or register to view PDF. | Permissions
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
Dyslipidemia: Current Therapies and Guidelines for Treatment
Edward T Carreras ,  Donna M Polk , 
Citation: US Cardiology Review 2017;11(1):10–5
DOI: https://doi.org/10.15420/usc.2016:9:2
HTML | ePub | Login or register to view PDF. | Permissions
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
Proprotein Convertase Subtilisin/Kexin 9 (PCSK9) Inhibition in Patients With or at High Risk of Coronary Heart Disease
Shane Prejean ,  Todd M Brown , 
Citation: US Cardiology Review 2017;11(1):16–7
DOI: https://doi.org/10.15420/usc.2017:5:2
HTML | ePub | Login or register to view PDF. | Permissions
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
Guest Editorial: Commentary on the Findings of the GLAGOV Randomized Clinical Trial
Jakub Podolec ,  Lukasz Niewiara , 
Citation: US Cardiology Review 2017;11(1):18–9
DOI: https://doi.org/10.15420/usc.11.1.GE
HTML | ePub | Login or register to view PDF. | Permissions
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.

Heart Failure

Cardiac Toxicity of Cancer Chemotherapy
Aarti Asnani ,  Randall T Peterson , 
Citation: US Cardiology Review 2017;11(1):20–4
DOI: https://doi.org/10.15420/usc.2017:2:2
HTML | ePub | Login or register to view PDF. | Permissions
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.

Interventional Cardiology

When to Use Bioresorbable Vascular Scaffolds
Xiaoyu Yang ,  Mohamed Ahmed ,  Donald E Cutlip , 
Citation: US Cardiology Review 2017;11(1):25–30
DOI: https://doi.org/10.15420/usc.2017:3:2
HTML | ePub | Login or register to view PDF. | Permissions
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
Dual Anti-platelet Therapy after Coronary Stenting: Rationale for Personalized Duration of Therapy
Donald E Cutlip , 
Citation: US Cardiology Review 2017;11(1):31–6
DOI: https://doi.org/10.15420/usc.2017:7:2
HTML | ePub | Login or register to view PDF. | Permissions
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
Guest Editorial: A Brave New World for Non-vitamin K Antagonist Oral Anticoagulants: Have We seen the Last of Warfarin?
Michela Faggioni ,  Michael C Gibson ,  Roxana Mehran , 
Citation: US Cardiology Review 2017; 11(1):37–8
DOI: https://doi.org/10.15420/usc.2017:6:1.GE
HTML | ePub | Login or register to view PDF. | Permissions
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.

Electrophysiology

Practical Aspects of Rotor Mapping in Catheter Ablation of Atrial Fibrillation
John M Miller , 
Citation: US Cardiology Review 2017;11(1):39–41
DOI: https://doi.org/10.15420/usc.2017:4:2
HTML | ePub | Login or register to view PDF. | Permissions
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.